Our Board

His background provides him a wide understanding of business management and advocacy at all levels of industry and Government. John is currently Chairman of the Northern Co-operative Meat Company, a globally recognised farmer owned Co-operative. He is currently Chairman of the Co-operative Alliance in northern New South Wales and represents the industry at both State and national levels.

John has a strong rural focus and has a particular interest in rural health issues. After being diagnosed with a potentially life threating invasive form of squamous cell carcinoma whilst living in western NSW, John appreciates the importance of support and information for patients having difficulty accessing specialised treatment.

John has a Bachelor of Agricultural Science (UNE) and is a member of the Australian Institute of Company Directors.

Daniel has extensive professional experience in Private Equity and Strategy fields through his work as a management consultant with McKinsey & Co in Sydney and New York, CEO of Sands Group, and now Managing Director of Redwood North, a Private Equity and Real Estate Investment Firm.

Daniel has completed an MBA from Columbia Business School in New York, an LLB/ B.Com (Accounting) from Bond University, and is a Graduate of the Australian Institute of Company Directors.

Alison has been a board director of Melanoma Patients Australia since 2016 and facilitates the MPA Support Group in Melbourne.

As a melanoma survivor, she is passionate about providing education, information and supporting others to live well with melanoma regardless of their stage of disease.

A committed patient and research advocate, she works in partnership with other consumers, health professionals, cancer organisations and researchers to develop and establish collaborative relationships within the community.

Alison is an associate investigator for several trials and studies and regularly reviews Cancer Australia and NHMRC grant proposals.  She has co-authored several journal papers with leading melanoma doctors and researchers.

Her affiliations and memberships include:

• Chair, Australian Melanoma Consumer Alliance
• Chair, Melanoma Research Victoria Consumer Reference Group
• The Clinical Practice Guidelines for the Diagnosis and Management of Melanoma Working Party
• Melanoma and Skin Cancer Trials – one of 14 Cancer Australia’s Cooperative Trials Groups
• Victorian Cancer Biobank
• Victorian Cancer Registry
• Cancer Council Victoria

She has experience in a range of clinical, policy, research, academic and senior management roles within health and social assistance, having worked in government, higher education, commercial and non-profit sectors. Marie-Claire’s most recent previous roles include: National Clinical Director for 1800RESPECT, the national telephone and online counselling service for people impacted by sexual assault and domestic and family violence and Director of Support Programs for Prostate Cancer Foundation of Australia.

Marie-Claire is currently working as a consultant with health, human services and social care organisations in the areas of strategic planning, psychosocial program innovation and development, quality assurance and improvement. She is also a national director of the Australian Association of Social Workers, currently serving as National Vice-President. Marie-Claire is a 2012 Winston Churchill Fellow. Her research involved an overseas study on the organisation of social work education and workforce planning in the United States, Canada, England and Denmark. She is currently undertaking a doctorate in social work at UNSW in Sydney.

• Fellow, Royal College of Surgeons of Edinburgh (Ad Hom) 2012
• Mayne Professor, Head of Discipline of Surgery, University of Queensland
• Director, Upper Gastro-intestinal and Soft Tissue Unit, Princess Alexandra Hospital.
• Chairman, Queensland Melanoma Project
• Director, Melanoma Patients Australia

Melanoma interests:
Surgeon involved in the management of patients with all stages of melanoma for 26 years.
Senior surgeon at the Melanoma Clinic at the Princess Alexandra Hospital

Research involvement:
Epidemiology of melanoma in Queensland – Collaboration with the Queensland Institute of Medical Research, Epidemiology Unit.
Assessment of the outcomes of patients with high risk primary and secondary melanoma.
Phase I-III trials in the surgical and medical management of patients with stage III and IV melanoma. These include locally based studies as well as collaboration in national and international trials.

She was subsequently diagnosed in mid-2013 at stage IV melanoma. She was treated with Keytruda as part of a trial from October 2013 to October 2015 and has shown no evidence of disease in regular scans since that time.